Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Major study to directly compare PEG-Intron and Pegasys for HCV

Sep. 30, 2003

Boehringer Ingelheim presents new HCV NS3 inhibitors

Sep. 30, 2003

Phase III hepatitis C trial of Zadaxin enrolled

Sep. 29, 2003

FDA grants orphan drug designation for IDN-6556 in liver transplantation

Sep. 29, 2003

Adolor announces positive results in phase III alvimopan study for postoperative ileus

Sep. 29, 2003

DanioLabs and Oxagen enter collaborative agreement for IBD

Sep. 23, 2003

New 5-HT2B antagonists and their use in GI disorders described by Pharmagene

Sep. 23, 2003

Eisai submits E.U. Pariet application for on-demand therapy of symptomatic GERD

Sep. 22, 2003

New tripeptides with HCV NS3-inhibitory activity covered by Boehringer Ingelheim patent

Sep. 19, 2003

Early response to antivirals predicts sustained response in chronic hepatitis C

Sep. 19, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...